Pancreatic cancer, pancreatic neuroendocrine tumor, solid pseudopapilloma of pancreas, metastatic carcinoma of pancreas and other solid space occupying diseases of pancreas
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Solid pancreatic mass was diagnosed or suspected by ultrasound or CT, MRI, PET-CT and other imaging examinations; 2. All subjects voluntarily signed the informed consent of EUS-FNA;
Exclusion criteria
Exclusion criteria: 1. Pregnant women; 2. Receiving anticoagulant or antiplatelet therapy without interruption or with severe coagulopathy (e.g., PLT 1.5); 3. Lesions deemed ineligible for EUS-guided biopsy sampling; 4. Severe cardiopulmonary dysfunction, can not tolerate the risk of intravenous anesthesia; 5. Refusal to sign the informed consent form for EUS-FNA; 6. Other contraindications to EUS-FNA;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnostic sensitivity;Diagnostic accuracy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse events;Diagnostic specificity;Operation time;Length of hospital stay; | — |
Countries
China
Contacts
The First Affiliated Hospital of Chongqing Medical University